Pediatric stem cell transplant and cancer patients often are discharged from the hospital with an external central venous line for medications, which parents or other caregivers must clean and flush daily to avoid potentially life-threatening bloodstream infections.
If an outpatient develops a bloodstream infection associated with the central line, the median charges to treat it total $37,000 for a hospital stay of six days for young immunocompromised patients, according to